Article
Current understanding of congenital myasthenic syndromes.
Current opinion in pharmacology - 1 Jun 2005
Engel Andrew G, Sine Steven M
Abstract excerpt
Investigation of congenital myasthenic syndromes (CMSs) disclosed a diverse array of molecular targets at the motor endplate. Clinical, electrophysiologic and morphologic studies paved the way for detecting CMS-related mutations in proteins such as the acetylcholine receptor, acetylcholinesterase, choline acetyltransferase, rapsyn, MuSK and Na(v)1.4. Analysis of electrophysiologic and biochemical properties of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
